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Abstract
Background: Sexually transmitted infections (STIs) during pregnancy result in neonatal morbidity and mortality,
and may increase mother-to-child-transmission of HIV. Yet the World Health Organization’s current syndromic
management guidelines for STIs leaves most pregnant women undiagnosed and untreated. Point-of-care (POC)
diagnostic tests for STIs can drastically improve detection and treatment. Though acceptable and feasible, poor
medication adherence and re-infection due to lack of partner treatment threaten the programmatic effectiveness of
POC diagnostic programmes.
Methods: To engender patient-provider trust, and improve medication adherence and disclosure of STI status to
sexual partners, we trained study nurses in compassionate care, good clinical practices and motivational
interviewing. Using qualitative methods, we explored the role patient-provider communications may play in
supporting treatment adherence and STI disclosure to sexual partners. Nurses were provided training in
motivational interviewing, compassionate care and good clinical practices. Participants were interviewed using a
semi-structured protocol, with domains including STI testing experience, patient-provider communication, and HIV
and STI disclosure. Interviews were audio-recorded, transcribed and analyzed using a constant comparison
approach.
Results: Twenty-eight participants treated for Chlamydia trachomatis (CT), Trichomonas vaginalis (TV), and/or
Neisseria gonorrhea (NG) were interviewed. Participants described strong communications and trusting relationships
with nurses trained in patient-centered care training and implementing POC STI diagnostic testing. However,
women described a delayed trust in treatment until their symptoms resolved. Women expressed a limited recall of
their exact diagnosis, which impacted their ability to fully disclose their STI status to sexual partners.
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Conclusions: We recommend implementing patient health literacy programmes as part of POC services to support
women in remembering and disclosing their specific STI diagnosis to sexual partners, which may facilitate partner
treatment uptake and thus decrease the risk of re-infection.
Keywords: Sexually transmitted infections, Point-of-care testing, Patient-provider communications, Pregnancy, HIV,
South Africa
Background
In 2017, South Africa reported that 30.8% of women at-
tending antenatal care (ANC) services were living with
HIV [1]. These findings emphasize the need to ensure
optimal implementation of prevention of mother to child
transmission (PMTCT) programs, including early and
immediate access to antiretroviral therapy (ART) [2, 3].
Sexually transmitted infections (STI) during pregnancy
may increase MTCT of HIV [4, 5]. A recent study from
Tshwane District, South Africa, reported that 47.8% of
pregnant women living with HIV attending their first
ANC visit for their current pregnancy tested positive for
an STI, of which nearly 60% were asymptomatic [2].
These results continue to suggest that syndromic man-
agement for STIs, especially during pregnancy, is insuffi-
cient to optimally detect and treatment these infections.
As point-of-care (POC) technologies for STI diagnosis
become available, especially in resource-poor health sys-
tems, pregnant women must be provided access to test-
ing services. Recent work to integrate STI molecular
diagnostic testing into ANC services for pregnant
women living with HIV was shown to be acceptable and
feasible [3]. However, to ensure optimal treatment out-
comes, patients must be counselled to complete their
course of treatment. Moreover, to reduce the risk of re-
infection, patients must be empowered and supported to
disclose their STI status to their partner(s), and the health
system must provide optimal services for partner treatment
uptake [6–8]. Implementing a comprehensive package of
services (i.e., diagnostic testing, medication adherence
counselling, STI status disclosure support and partner
treatment uptake) will certainly improve sexual, reproduct-
ive and maternal-child health outcomes [3, 9]. However, to
ensure optimal clinical outcomes of HIV and STI services,
effective patient-provider communication must engender
patient trust and engagement in care [10–14]. Unfortu-
nately, challenges that affect patient-provider communica-
tion include women’s internalized shame and disease-
associated stigma that limits their access to care [15]. It has
also been shown that patients experience stigma and
discrimination from nurses, especially with regard to STI
testing and treatment, which can reinforce STI stigma dur-
ing pregnancy [16, 17]. As a result, women living with HIV
and diagnosed with an STI report lower rates of disclosure
to their sexual partners [18, 19].
In South Africa, nurse training in patient-provider com-
munication is limited, as clinical care is generally prescrip-
tive with few opportunities to engage in conversations
about specific diagnosis and treatment plans [20]. Al-
though nurse providers can build relationships with pa-
tients over time, in many African settings patients do not
see the same nurse at subsequent clinic visits. Conse-
quently, this can compromise a patient’s ability to under-
stand their diagnosis and treatment, leading to high rates
of non-adherence and reluctance to access care [21].
While patient-provider communications can directly im-
pact patient outcomes, so too can a patient’s health liter-
acy [22–24]. For example, lack of basic health knowledge
may limit a patient’s understanding of the importance of
daily adherence and disclosing diagnoses to partners [21].
Research has also shown that disclosure of HIV or STI
status is important to PMTCT programming as involving
male partners can reduce sexual risk, improve adherence,
and facilitate communication between partners [25, 26].
Moreover, disclosure to partners has been shown to facili-
tate partner testing and treatment uptake [27]. Given that
STIs often include risks of reinfection with continued ex-
posure, any opportunity to increase partners' treatment
may directly impact sexual and reproductive health, and
in the context of pregnancy, may directly reduce risk of in-
fant morbidity and mortality [28–30].
As part of a larger study to assess the acceptability and
feasibility of implementing comprehensive POC STI
diagnostic testing, same day treatment and partner treat-
ment services into antenatal care services, we trained
study nurses in compassionate care, good clinical prac-
tices and motivational interviewing. This was done to
engender patient-provider trust, improve medication ad-
herence, and support disclosure of women’s STI status
to sexual partners. In this sub-study we qualitatively ex-
plored the role patient-provider communications played
in supporting treatment adherence and STI disclosure to
sexual partners, with the goal of informing and improv-
ing future services and support as part of comprehensive
POC STI testing services.
Methods
We nested a qualitative sub-study within a larger, previ-
ously described cohort study aimed at integrating STI
diagnostic testing into ANC services [2, 3]. Briefly, in the
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larger study pregnant women living with HIV were offered
diagnostic testing via GeneXpert® (Sunnyvale, California,
U.S.A.) for Chlamydia trachomatis (CT), Neisseria gonor-
rhoeae (NG), and Trichomonas vaginalis (TV); in South
Africa, syndromic management is standard care [31].
Women with a positive STI test result were provided tar-
geted treatment and asked to return to the clinic 3 weeks
post-treatment for re-testing (i.e., test-of-cure, TOC) and
additional treatment if necessary. As part of the STI test-
ing intervention package, at the time of diagnosis study
nurses explicitly provided the clinical and local vernacular
names of the STI(s) the participant tested positive for, the
health consequences to her, her unborn child and sexual
partner(s) if the STI(s) remained untreated. Nurses also
provided support for disclosing their STI status to sexual
partners, including disclosure counselling and engaging in
conversation about how a participant may approach a
conversation with their sexual partner(s). Regarding part-
ner treatment, women were provided an option to take to
their partners either a treatment pill packet or a referral
letter for STI clinical services. This qualitative sub-study
aimed to assess the experiences of pregnant women living
with HIV with nurses providing POC STI diagnostic test-
ing with same day treatment.
Research nurse training
All research nurses completed a two-week training in
the study procedures, South African guidelines for STI
management and maternity care, and Good Clinical
Practice that integrated clinical ethics case studies. In-
cluded in this two-week training, research nurses also
completed 10 h of training in compassionate care and
motivational interviewing skills as it applied to STI dis-
closure and referral counseling [32], as well as training
in motivational interviewing that is not part of standard
nurse educational curriculum in South Africa. Practice-
based approaches were integrated into study training
and preparation activities. This allowed nurses to build
upon their clinical experiences while learning how to
apply their new skills during counseling simulations
prior to initiating study enrollment procedures. Through
this training, the objective was to develop nurse skills in
building a clinical relationship with study participants,
and nearly all nurses saw the same participants through-
out the study. Additional trainings were provided
throughout study period to ensure that the research
nurses were updated on study activity changes including
those informed by any clinical cases that were discussed
with the study clinician.
Participant recruitment
Participant recruitment has been previously described
for the larger study [8]. For the qualitative sub-study,
participants also had to: 1) test positive for CT, NG,
and/or TV at their first ANC visit, 2) return to the clinic
for a test-of-cure, and 3) provide informed consent to
participate in a qualitative in-depth interview (IDI).
Upon providing informed consent for the IDI, partici-
pants were interviewed in a private space within or out-
side the clinic by trained study staff.
Data collection
IDIs were conducted using a semi-structured protocol
that covered the domains of testing and nurse experi-
ences, partner communication, STI disclosure to part-
ners and their response, partner treatment uptake,
relationship decision-making, HIV disclosure and finan-
cial independence. Interviews were conducted in the
participants preferred language (i.e., English, seTswana
or sePedi), with interviews lasting between 35 and 90
min [33]. All IDIs were audio-recorded, translated and
transcribed with quality checks conducted by an inde-
pendent researcher.
Data analysis
Five researchers open-coded seven transcripts and devel-
oped a codebook to be used for all transcripts. All codes
indicated either preventative or risk behaviors. Two re-
searchers then coded the remaining transcripts following
a random assignment process. Quality assurance proce-
dures were applied to ensure that coding was correctly
utilized and documented. The research team utilized a
constant comparison approach to analyze data. Themes
were developed over time, with a focus on how the rela-
tionship between the nurse and participant developed
during the study [34]. Our approach integrated memo
writing, quantification of relationship characteristics, and
causal diagrams—visual depictions of possible relation-
ships between different influences contributing to
women’s experiences with nurses—as a means to refine
understandings of the patient-provider relationship.
Findings from transcripts, causal diagrams, and memos
were triangulated to: 1) assess consistency across data
sources, and 2) identify themes developing from discus-
sions over time regarding data interpretation [22, 35].
The research team met every week for 3 months to
complete the analysis process.
Data representation
Interviewers and participants are designated with an ‘I’
(interviewer) and ‘P’ (participant) respectively. Each
quote from a participant is labeled by her age and STI
diagnosis at baseline, which is written using the respect-
ive acronym: Chlamydia trachomatis (CT), Neisseria
gonorrhoeae (NG), and Trichomonas vaginalis (TV).
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Results
A total of 28 women were recruited to complete inter-
views, which lasted an average of 55 min. All participants
were black African with a mean age of 28.7 years
(range = 22–39 years), a median gestational age of 19
weeks (IQR = 11.5–23); 24 (86.7%) had 1 or more chil-
dren already. Over half were unemployed, and > 90%
had, at most, a high school diploma/matriculation de-
gree. Regarding partner characteristics, 14 (50%) of
women reported that their partner had another sexual
partner, and 5 (18%) reported that they were unsure
if their partner had another partner. A total of 12
women (42.9%) were diagnosed with HIV at their first
antenatal care visit. By study completion, all inter-
viewed women were successfully treated for STI’s and
tested negative. Through the interviews, we found
that women valued the nurses’ care and medical ex-
pertise. However, women didn’t trust the treatment
immediately, and they demonstrated limited recall of
their diagnosis and treatment.
Role of counseling and support from nurses in promoting
adherence to and trust in treatment
Supportive behavior from nurses was identified as im-
portant to participant’s treatment adherence and trust
levels throughout the testing and treatment processes.
Participants initially reported fear and guilt about their
diagnoses: “I felt like I let myself down. I don’t know how,
but yah, I felt as if I let myself down by.. then I was
scared for my baby” (25-year old with CT & TV). One
participant recalled upon receiving her diagnosis: “I felt
so lonely so sad sometimes I felt like ending my life but
then I thought about my baby” (28-year old with CT &
NG). Support in the form of counseling at the time of
diagnosis was identified by participants as being linked
to stress reduction, confidence building, and skill build-
ing for disclosure to partners. Supportive behavior pro-
vided by nurses is described in the case below:
P: She spoke to me like.. what can I say, like a friend.
We were like speaking as [if we were] having a
friendly conversation … A person speaking to you
friendly, openly. You asking questions, or [them] ask-
ing you do you have any questions. It makes … me
feel relieved …. Because if a person can give me the
space to express what I feel or express what I do not
understand about whatever situation I’m in like
now. But, she gave me everything I would like
[health information needed, and then] okay fine, I
understand. Mm.
I: And, how did you feel after the counselling?
P: I felt free … (25-year old with CT & TV)
Friendly nurses were described as those who allowed
patients to ask questions without expressing judgment.
Friendly care was differentiated from past negative care
experiences: “I was happy because I was getting help and
the one who was helping me she gave me the support in
everything … when you get to the clinic and you will find
a person who will not judge and she will show you the
way like some [other nurses] will judge and they would
not show you what to do and what you mustn’t do” (26-
year old with TV). Nurses also helped women to feel
confident in their ability to recover with treatment, help-
ing one participant to: “realize [the STI is] not [a] threat-
ening disease it’s like you can accept it live with it longer
and take treatment so that [it’s] not something you can
be afraid of am not dying tomorrow or something you
must have a positive mind” (28-year old with CT & NG).
Counseling provided by nurses regarding STI diagnoses
helped patients to understand that proper treatment ad-
herence would cure their infection.
Having developed a personal, trusting relationship
with nurses additionally promoted adherence, along with
symptom alleviation: “because I trust the person who
gave me the medication and when I was using them after
two days I started seeing the differences and I was getting
better” (26-year old with TV). Supportive nurses helped
women to feel confident disclosing their status to part-
ners, as described by one participant:
I: Ok, how did you feel about the counselling?
P: The counselling was good because it motivated me
like to tell him [partner], because at first I was
afraid that can I tell him or not? How will he react
or something …
I: How did you feel before telling him?
P: Before telling him, I felt, like most of the time,
[that] I was blaming myself thinking. That maybe it
was because of me … I didn’t have a clear answer
[explanation for how she acquired the STI] like, or it
was a disappointment, but at the end, I realized that
there was change in my life …
I: Ok, how did you feel after you told him this?
P: For me, it was a relief because I was holding
something. That even if I don’t tell him, it’s going to
haunt me. But, the minute I told him like everything,
it was at ease. (28-year old with CT & NG).
Supportive counseling by nurses at the time of diagno-
sis helped to alleviate initial anxiety that women
expressed toward disclosing their diagnoses to their
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partners, and to have less fear surrounding their STI diag-
noses in general. Supported women felt less guilt and
more confidence when approaching their treatment plan.
Influence of symptom reduction and negative re-test on
trust of treatment over time
Despite trust in nurses and positive experiences with
counseling, most participants did not immediately trust
the treatment provided to them. This mistrust was
grounded in hesitancy to take medication in general and
uncertainty about the effectiveness of the STI treat-
ments, which changed once their symptoms went away.
Pill hesitancy was reflected in the case below:
[On the] first day, I was like, ‘Are they crazy? Should
I drink all these tablets? Are they insane? How am I
going to do it?’ … because they gave me like … two
[pills] of each the first time [for STI treatment] and
then just one of the ARV’s, [and] so I was like, ‘How
am I going to drink all these pills at once?’, because
I wasn’t drinking any pills before. So now … every-
thing has to change. I need to get used to drinking
them, and some even has a smell. And then, some-
times you feel nausea [after taking the pills]; you
want to vomit … (28-year old with CT & NG).
In addition to this participant testing positive for two
STIs, she was also diagnosed with HIV at her first ANC
visit. As such, she was concerned about the number, size
and smell of all the pills she was given. This participant’s
concern was further exacerbated by the fact that she re-
ceived multiple diagnoses at once. This was evident in
her statement ‘everything has to change’ in her life—
from taking no pills to taking many for STIs with regular
HIV treatment. Many women acknowledged that their
health changed significantly in one clinical visit, and that
being diagnosed with HIV and an STI was a lot to
understand and accept at once.
Once participants began their treatment, they were
not certain that the treatment would work as explained
to them by the nurse. Some stated that they would re-
turn to the clinic if ‘something goes wrong’. However,
after being on their STI treatment for a few days, partici-
pants noticed their symptoms subsiding, as a participant
stated: “It was good because after two days, when I
checked my underwear [before I tested for positive for
STIs] I was feeling some smelly, but after two days that
smell was gone” (26-year old with TV). Many partici-
pants experienced increased trust in their medication
after their symptoms had disappeared while on treat-
ment. This trust was further bolstered when they re-
ceived a negative STI result in their follow-up test-of-
cure: “Yes, because first it was positive then they gave us
the medication then when I came back the second time it
was negative so that was all” (29-year old with CT).
In addition to bolstering trust, negative re-testing
experiences provided closure. This could be seen both
from the finality of the above participant’s wording of
“that was all” (29-year old with CT) to the statement
of another participant: “they gave me pills and on the
next visit told me am alright” (24-year old with CT &
NG). Receiving a final negative test result also reaf-
firmed positive experiences with the nurses and with
the health care system, as shown in the below case
study. The participant describes her experience with
testing and treatment:
P: … We [research nurse] ran a test [STI] … the re-
sult came positive. Then, they gave me treatment,
[and] then I went home. On six weeks, they told me
no … You are negative now. Then, I felt yo those
people were so helping me, because I didn’t know
that I have such … STIs in me. I didn’t know about
those STI but, after participating in the study, I knew
lot of STIs …
I: And how did you feel when you left the study and
they said everything is okay?
P: I was so happy, because I was cured... Yes, they
told me that now you are fine. You are cured. You
don’t have that STI anymore
(31-year old with CT)
This participant had two sequential STI-positive test
results requiring her to complete two rounds of treat-
ment. After the second round of treatment, the negative
STI test result allowed the participant to see that the
nurses were “so helping [her]” by teaching her about
STIs and STI treatment, and by making sure that she
was cured. She also expresses “I was so happy,” speaking
to a sense of delight and relief that participants may
have felt to leave their experiences with STIs behind
them.
Limited recall of medical information, an indicator of
patient trust, may impact the ability to disclose to sexual
partners
Although participants were able to speak clearly about
their symptoms and experiences, most participants could
not recall their exact diagnoses nor the treatment that
they were given, stating, “Yes, I forgot but they gave me
tablets … I think it was Chlamydia and Gonorrhea
something like that” (29-year old with CT). The below
case study is a good example of a typical exchange
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regarding the details that participants retained or had
forgotten following the conclusion of their treatment:
I: Can you remember the name of the STI?
P: No, I can’t. No, I don’t remember
I: What were your thoughts on your diagnosis?
P: Mm … because I wanted to protect my child you
see … I didn’t want him or her to be affected [by the
STI]. So that’s why I decided to take [the] test.
I: Do you think the infection is dangerous?
P: No, because it’s curable. It’s not that dangerous.
I: During your last clinic visit, can you tell me what
medication you were given?
P: Mm..I was given pills to clean for [to treat the]
STI that I was diagnosed with...
I don’t remember the name but only the pills.
(26-year old with TV)
Participants remembered the parts of the STI ex-
perience that were important to them, such as their
motivation to protect their child or the memory of
taking the pills, but generally did not retain specifics
as to the STI itself or the name of the medication.
Rather, participants seemed to rely upon the nurse
for this information and didn’t ask questions that
could lead to ownership and recall of their diagno-
ses and treatments by making statements like, ‘Be-
cause sister [nurse] won’t give me medication that’s
not working …’ (29-year old with CT). This shift in
focus to the nurses’ role may indicate that patient’s
trust of the nurses’ expertise may diminish women’s
engagement and focus to remember their diagnosis
or treatment. Furthermore, this dependency on
nurses along with limited recall of medical details
likely impacted women’s ability to fully disclose to
their partners. One participant stated, “When [the
nurse] was talking, I wished that my husband was
here to listen because she talked so simple and you
could understand [the diagnosis and treatment]”
(26-year old with TV). In expressing the desire for
her partner to be present to listen to the nurse, this
participant is acknowledging her own discomfort
and uncertainty that she can explain the STI and
treatment to her partner so that he “could
understand.”
Discussion
This qualitative study was designed to explore the expe-
riences of pregnant women living with HIV regarding
their communications with trained nurses while partici-
pating in a STI POC test and treat study. Our results re-
veal that nurses were able to establish and maintain
trust with participants while engaged in the study. How-
ever, women had limited recall of their specific STI diag-
nosis and treatment, with implications for STI status
disclosure to sexual partners and thus uptake of treat-
ment by partners.
Patient-centered care training may mitigate HIV and STI
shame
We found that recurring, patient-centered care fostered
a positive STI testing and treatment experience for preg-
nant women living with HIV, with no descriptions of
shame associated with being pregnant while living with
HIV [14, 36]. Often, pregnant women concurrently diag-
nosed with a STI and HIV are stigmatized by nurses for
their infection and the assumed risky sexual behaviors as-
sociated with their infection(s) [37]. Our study suggests
that nurse training in compassionate care and motiv-
ational interviewing, as components of a comprehensive
POC STI test and treat intervention, helped women to
mitigate feelings of guilt and shame, allowing some of
them to disclose their STI status to their partners and
more confidently approach their treatment [20, 38]. Fur-
thermore, the care participants received from study nurses
was described as non-judgmental compared to their previ-
ous care experiences. Finally, most women understood the
implications of their diagnoses, their capacity to recover,
and motivation to complete treatment and disclose their
STI diagnosis to their partner(s) as a way to protect their
unborn child [8].
Interpretation of limited recall around STI diagnosis and
treatment details
A positive patient-provider relationship did not appear
to enhance women’s medical understanding of their STI
nor their treatment [21]. When recounting their treat-
ment experiences, participants spoke almost exclusively
of the emotional support they received during counsel-
ing, but did not discuss the medical information they
were given about their STIs. Such a tendency may indi-
cate a limited recall or understanding of their diagnosis
of treatment. This apparent contradiction may shed light
on how women of lower socioeconomic background,
poor health literacy or lower educational attainment
move through the health care system [39, 21]. Further-
more, it is likely that some of these factors inherently
interact with each other. For instance, an educational
background ending in secondary school may not delve
into science as thoroughly as in higher education, which
Medina-Marino et al. BMC Public Health          (2020) 20:577 Page 6 of 9
influences health literacy and ability to understand med-
ical terminology [40, 41]. Limited health literacy in turn
may affect the ability to ask the right questions or absorb
basic information their providers are providing them
[42]. This disconnect may create a gap in patient-
provider communication, where the provider feels they
have given the patient the necessary information, but the
patient may not actually have received it [43]. Ultimately,
without a proper understanding of what STI they were
diagnosed with and what treatment they are taking, indi-
viduals may struggle to explain to their partners the ur-
gency to seeking care, the treatment they are taking or
the necessary steps to prevent reinfection.
Study limitations
Our study is limited by the lack of interviews conducted
with women who had a negative test result. As such, we
cannot assess the role of trust and health literacy on re-
ceiving a negative test result. This could have major im-
plications if a woman were to present with an incident
STI later in pregnancy. Another study limitation is that
we did not assess a women’s true level of health literacy.
As such, we may not have clear enough insight on how
to further improve the provision of health information
provided in our current intervention. Consequently, add-
itional research is needed to understand what basic level
of health literacy is needed to maximize trust in point-
of-care testing during pregnancy.
Conclusions
South African pregnant women living with HIV trusted
nurse treatment of their STI infection in this study.
Given how participants described patient-centered care
characteristics of study nurses, these results are likely a
result of the specialized nurse training we provided in
motivational interviewing, compassionate care and good
clinical practice. However, participants had limited recall
of their diagnosis and treatment. This lack of recall may
pose significant barriers to disclosure and care self-
management. Furthermore, most women described an
over-reliance on nurses, which may be reflect limited
health literacy among women and men in this setting.
Of note, we have reported that ~ 80% of women in our
larger study with an STI returned for their test-of-cure
visit [44]. While this represents a high level of study re-
tention, the experiences of women that did not return,
and thus could not be interviewed, may be qualitatively
different from women that were interviewed.
As POC diagnostics for STIs are scaled up, ensuring
their maximal public health impact will require more
than just optimal testing coverage. Towards this, when
an individual discloses their STI status to their sexual
partner(s) and those partners seek treatment, the risk of
re-infection can be strongly diminished. Conversely, any
barriers to STI status disclosure can have a direct impact
on partner treatment uptake, and thus re-infection risk.
To ensure that POC STI diagnostic testing interventions
have the desired public health effect, a comprehensive
POC intervention package that includes improved health
literacy, partner notification support and counselling and
partner treatment uptake, must be implemented.
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